| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.091 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |